| Literature DB >> 35283708 |
Sultan Deniz Altindag1, Fulya Cakalagaoglu2, Gokay Karaca3, Nurullah Yuceer4.
Abstract
Xanthomatous meningioma is an extremely rare subtype of metaplastic meningiomas with few cases reported in the literature. Histopathologically, it is composed of oval-shaped cells that have central nuclei and cytoplasm with lipid-filled vacuoles, resembling macrophages. Here, the authors present a case of xanthomatous meningioma and discuss the hypotheses related to its origin and the differential diagnosis. A 40-year-old woman presented with an increased headache complaint over the past month. A computed tomography scan revealed a heterogeneous mass on the right parietal lobe, following which a right craniotomy was done. Microscopic examination showed neoplastic meningothelial cells with whorl formation and areas of xanthomatous changes. Both meningothelial and xanthomatous cells were positive with vimentin, progesterone, and epithelial membrane antigen. CD68 and lysozyme were expressed only in the xanthomatous component, and there was no expression with periodic acid-Schiff (PAS) stain and PAS-diastase. As the diagnostic criteria of atypical meningioma were not observed, a diagnosis of xanthomatous meningioma, WHO grade I, was made. Owing to the characteristic xanthomatous changes, its differential diagnosis includes grade II clear cell meningioma, Rosai-Dorfman disease, and hemangioblastoma. To avoid misidentifying these cells as macrophages, a high degree of awareness of this unique subtype of meningioma is required. Copyright:Entities:
Keywords: Histogenesis; Meningioma; lipid-filled; meningeal neoplasms; metaplastic; xanthomatous
Year: 2022 PMID: 35283708 PMCID: PMC8869274 DOI: 10.4103/sjmms.sjmms_705_20
Source DB: PubMed Journal: Saudi J Med Med Sci ISSN: 2321-4856
Figure 1(a and b) Axial head computed tomography scan revealing heterogeneous mass starting from the right parietal region and extending toward the midline, brain parenchyma has been pushed, and the mass causes compression in the lateral ventricle
Figure 2Meningothelial tumor cells with xanthomatous changes (H and E, ×100), inset: Cholesterol clefts with meningothelial and xanthomatous cells (H and E, ×100)
Figure 3Immunohistochemical features: (a) Vimentin (×200) and (b) epithelial membrane antigen (×100) were expressed both meningothelial and xanthomatous components. (c) CD68 (×100) and (d) lysozyme (×400) were expressed in the xanthomatous component
Clinicopathological comparison of xanthomatous meningioma cases
| Case number | Age (Years) | Gender | Location | Immunohistochemistry findings | Reference number |
|---|---|---|---|---|---|
| 1 | 24 | Male | Right parietal | CD68 (+), vimentin (+) | [ |
| 2 | 2 | Female | Posterior pyramid | EMA (+) | [ |
| 3 | 10 | Male | Right frontal | CD68 (+), HAM56 (+), vimentin (+) | [ |
| 4 | 58 | Female | Right frontal | EMA (+), Ki-67 (<5%) | [ |
| 5 | 27 | Female | Right petrous bone | EMA (+), S100 (−), Ki-67 (<5%) | [ |
| 6 | 49 | Female | Left parietal | EMA (+), S100 (−), Ki-67 (<5%) | [ |
| 7 | 59 | Female | Right frontal | EMA (+), S100 (−), Ki-67 (<5%) | [ |
| 8 | 70 | Female | Left sphenoid, small wing | EMA (+), S100 (−), Ki-67 (<5%) | [ |
| 9 | 79 | Male | Left occipital | EMA (+), S100 (−), Ki-67 (<5%) | [ |
| 10 | 61 | Female | Right occipital to parietal | EMA (+) CD68 (+) vimentin (+) lysozyme (+) Ki-67 (2.2%) | [ |
| 11 | 76 | Male | Left parasagittal to frontal | EMA (+) CD68 (+) vimentin (+) lysozyme (+) adipophilin (+) Ki-67 (2.1%) | [ |
| 12 | 22 | Male | Sinus region | EMA (+), vimentin (+), GFAP (−), Ki-67 (1%) | [ |
| 13 | 68 | Male | Right frontal | EMA (+), vimentin (+), GFAP (±), Ki-67 (1%) | [ |
| 14 | 24 | Female | Tempora-parieto-occipital region | EMA (+), Ki-67 (3.2%) | [ |
| 15 | 32 | Male | Right frontal to parietal | EMA (+), CD68 (+) adipophilin (+) (xanthomatous area), Ki-67 (3%) | [ |
| 16 | 61 | Male | Right parietal | EMA (+), vimentin (+), CD68 (+), GFAP (−), Ki-67 (1%) | [ |
| 17 | 83 | Female | Left fronto-temporal region | EMA (+), PR (+), Vimentin (+), S-100 (+), CD68 (+), CD11c (+), p53 (weak+), CK (–), CD34 (–), Ki-67 (< 1%) | [ |
| 18. | 40 | Female | Right parietal | EMA (+), CD68 (+), vimentin (+), PR (+), lysozyme (+) Ki-67 (<5%) | Present case |
EMA – Epithelial membrane antigen; PR – Progesterone; GFAP – Glial fibrillary acidic protein; PR – Progesterone receptor; CK – Cytokeratin